首页> 外国专利> FORMULATION FOR DELIVERING LIPID-LOWERING DRUGS BY ORAL TRANSMUCOSAL ADMINISTRATION

FORMULATION FOR DELIVERING LIPID-LOWERING DRUGS BY ORAL TRANSMUCOSAL ADMINISTRATION

机译:口服经皮给药配制降脂药的配方

摘要

The invention relates to a formulation for delivering by oral transmucosal administration at least one lipid-lowering active principle, preferably from the statin family, said formulation including said active principle in the base or salt form, an aqueous alcohol solution titrating at least 30° alcohol, and optionally a pH correcting agent and/or an antioxidant, said active principle being in a stable and completely dissolved state in the aqueous alcohol solution. The invention also relates to a method of preparing said formulation and to the use thereof, preferably in single-dose packaging, for treating and preventing hyperlipemia and/or cardiovascular conditions.
机译:本发明涉及通过口服粘膜给药递送至少一种降脂活性成分(优选地来自他汀类)的制剂,所述制剂包括碱或盐形式的所述活性成分,滴定至少30°酒精的醇水溶液。以及任选的pH校正剂和/或抗氧化剂,所述活性成分在酒精水溶液中呈稳定且完全溶解的状态。本发明还涉及制备所述制剂的方法及其在治疗和预防高脂血症和/或心血管疾病中的用途,优选在单剂量包装中的用途。

著录项

  • 公开/公告号EP2379054A1

    专利类型

  • 公开/公告日2011-10-26

    原文格式PDF

  • 申请/专利权人 PEROVITCH PHILIPPE;MAURY MARC;

    申请/专利号EP20090805727

  • 发明设计人 PEROVITCH PHILIPPE;MAURY MARC;

    申请日2009-12-17

  • 分类号A61K9;A61K31/19;A61K31/216;A61K31/22;A61K31/351;A61K31/397;A61K31/40;A61K31/404;A61K31/505;A61K47/10;A61P3/06;A61P9;

  • 国家 EP

  • 入库时间 2022-08-21 17:53:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号